Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Neuphoria Therapeutics (NEUP) Tax Provisions (2024 - 2025)

Neuphoria Therapeutics has reported Tax Provisions over the past 2 years, most recently at -$34794.0 for Q4 2025.

  • Quarterly Tax Provisions fell 399.72% to -$34794.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $51052.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $61.0 for FY2025, 100.07% up from the prior year.
  • Tax Provisions was -$34794.0 for Q4 2025 at Neuphoria Therapeutics, roughly flat from -$34793.0 in the prior quarter.
  • Over five years, Tax Provisions peaked at $201825.0 in Q2 2025 and troughed at -$132187.0 in Q3 2024.